Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q2 2026 Earnings

May 7Confirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.62

-0.47

-0.31

-0.15

Details

Expected EPS

-0.458968

Actual EPS

-0.4

Surprise EPS

0.06

Surprise Percent

+12.85%

Description

⁨NewAmsterdam Pharma Company NV⁩ (⁦NAMS⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.